Table 1.
Clinical information of the cohort.
| Strain | Age * | Gender | Underlying Diseases | Clinical Department |
Antibiotic Treatment | Outcome | Year of Isolation |
|---|---|---|---|---|---|---|---|
| E1 | 3 Y | male | acute myeloid leukemia | hematology | meropenem + amikacin | recovery | 2019 |
| E2 | 13 Y | male | acute lymphoblastic leukemia, post allo-HSCT | hematology | meropenem + amikacin, tigecycline | automatically discharged | 2017 |
| E3 | 1 M | female | neonatal sepsis, premature infant | neonatology | meropenem | recovery | 2020 |
| E4 | 9 D | female | necrotizing enterocolitis, neonatal sepsis | neonatology | meropenem | recovery | 2020 |
| E5 | 4 M | male | congenital atresia of biliary tract | gastroenterology | imipenem | recovery | 2016 |
| E6 | 11 Y | male | T lymphoblastic leukemia/lymphoma | hematology | tigecycline + amikacin | recovery | 2020 |
| E7 | 3 Y | female | acute lymphoblastic leukemia | hematology | meropenem + amikacin | recovery | 2017 |
| E8 | 12 D | male | neonatal sepsis, premature infant | neonatology | meropenem | recovery | 2017 |
* Y, M and D in this column represent years, months and days, respectively.